Breaking News Instant updates and real-time market news.

PRQR

ProQR Therapeutics

$6.27

-0.64 (-9.26%)

18:06
11/18/19
11/18
18:06
11/18/19
18:06

ProQR Therapeutics treatment of retinal dystrophy in P23H granted orphan status

ProQR Therapeutics' treatment of retinal dystrophy in P23H gene mutation was granted FDA orphan designation, according to a post to the agency's website. Reference Link

PRQR ProQR Therapeutics
$6.27

-0.64 (-9.26%)

03/27/19
CANT
03/27/19
NO CHANGE
Target $40
CANT
Overweight
ProQR Therapeutics spin-out 'smart, but not surprising,' says Cantor Fitzgerald
Cantor Fitzgerald analyst Eliana Merle thinks ProQR Therapeutics' spin-out of its dystrophic epidermolysis bullosa program is a "smart, but not surprising," strategic move. Given that the company has communicated it wants to focus on its ophthalmology programs, investors are unlikely to find this announcement about the skin program spin-out surprising, Merle tells investors in a research note. The analyst keeps an Overweight rating on ProQR Therapeutics with a $40 price target.
10/09/19
CANT
10/09/19
NO CHANGE
Target $40
CANT
Overweight
ProQR shares could more than double on tomorrow's data, says Cantor Fitzgerald
Cantor Fitzgerald analyst Eliana Merle reiterates an Overweight rating on ProQR Therapeutics with a $40 price target ahead of tomorrow's data update on lead program QR-110, which is in development for LCA10, a rare genetic form of blindness. Investors view ProQR and QR-110 as a "show-me story," but these data could lift a "significant overhang" around platform safety and serve as a "key piece of clinical de-risking" for QR-110's Phase 2/3 trial under way, Merle tells investors in a research note partially titled "A double by this time tomorrow?". The analyst thinks the stock could trade up 50%-150% tomorrow versus downside to its cash position of ~$2 per share, or ~65%.
10/10/19
SBSH
10/10/19
NO CHANGE
Target $40
SBSH
Buy
ProQR Therapeutics price target raised to $40 from $34 at Citi
Citi analyst Yigal Nochomovitz raised his price target on ProQR Therapeutics to $40 from $34, stating that he disagree's with the market's initial take on the company's updated data on sepofarsen. Given his view that the 12-month data validate the treatment benefits observed at 3 months, Nochomovitz increased his odds on the success for sepofarsen in patients with Leber's congenital amaurosis 10 to 70% from 50% and keeps his Buy rating on the stock. In afternoon trading, ProQR shares are down 26c, or 4%, to $5.95.
11/06/19
JMPS
11/06/19
NO CHANGE
JMPS
JMP Securities continues to recommend ProQR Therapeutics after Q3 report
JMP Securities analyst Liisa Bayko reiterated an Outperform rating and $25 price target on ProQR Therapeutics after the company reported Q3 results. The analyst noted that the company ended the quarter with ~$137M in pro forma cash, which management guided to as sufficient runway into 2022. Bayko sees the next major catalyst for ProQR being proof-of-concept data for QR-421a in Usher syndrome in Q1 of 2020, adding this this is "a significant opportunity... which we estimate could reach ~$1B."

TODAY'S FREE FLY STORIES

AGM

Federal Agricultural Mortgage

$82.51

0.56 (0.68%)

10:46
12/05/19
12/05
10:46
12/05/19
10:46
Conference/Events
Federal Agricultural Mortgage management to meet with BTIG »

Meeting to be held in the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

LBTYK

Liberty Global

$20.96

(0.00%)

10:45
12/05/19
12/05
10:45
12/05/19
10:45
Options
Liberty Global call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:45
12/05/19
12/05
10:45
12/05/19
10:45
General news
Breaking General news story  »

6-Month Bill Announcement…

10:45
12/05/19
12/05
10:45
12/05/19
10:45
General news
Breaking General news story  »

3-Month Bill Announcement…

10:45
12/05/19
12/05
10:45
12/05/19
10:45
General news
Breaking General news story  »

6-Month Bill Announcement…

10:45
12/05/19
12/05
10:45
12/05/19
10:45
General news
Breaking General news story  »

3-Month Bill Announcement…

KR

Kroger

$26.79

-0.85 (-3.08%)

10:41
12/05/19
12/05
10:41
12/05/19
10:41
Earnings
Kroger sees 'double-digit' growth in Q4 EPS »

Asked by an analyst on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

WWR

Westwater Resources

$2.50

-0.025 (-0.99%)

, UUUU

Energy Fuels

$2.14

0.24 (12.63%)

10:36
12/05/19
12/05
10:36
12/05/19
10:36
Periodicals
White House panel pushes U.S. to buy uranium from U.S. miners, Bloomberg says »

A White House task force…

WWR

Westwater Resources

$2.50

-0.025 (-0.99%)

UUUU

Energy Fuels

$2.14

0.24 (12.63%)

URG

UR-Energy

$0.59

0.0526 (9.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TNP

TEN, Ltd.

$3.52

0.05 (1.44%)

10:35
12/05/19
12/05
10:35
12/05/19
10:35
Hot Stocks
TEN, Ltd. announces charter extension for LNG carrier »

TEN announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CC

Chemours

$14.68

-0.735 (-4.77%)

10:35
12/05/19
12/05
10:35
12/05/19
10:35
Options
Chemours put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

KELYA

Kelly Services

$21.54

0.11 (0.51%)

, KELYB

Kelly Services

$23.00

(0.00%)

10:34
12/05/19
12/05
10:34
12/05/19
10:34
Hot Stocks
Kelly Services announces agreement to sell, lease back corporate headquarters »

Kelly Services has…

KELYA

Kelly Services

$21.54

0.11 (0.51%)

KELYB

Kelly Services

$23.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GLNCY

Glencore

$0.00

(0.00%)

10:31
12/05/19
12/05
10:31
12/05/19
10:31
Hot Stocks
SFO confirms investigation into suspected bribery at Glencore »

Earlier, the U.K. Serious…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LPNT

LifePoint

$0.00

(0.00%)

, UHS

Universal Health

$141.30

0.37 (0.26%)

10:31
12/05/19
12/05
10:31
12/05/19
10:31
Periodicals
Hospital groups sue to stop Trump price-transparency requirement, WSJ says »

Hospital groups are suing…

LPNT

LifePoint

$0.00

(0.00%)

UHS

Universal Health

$141.30

0.37 (0.26%)

THC

Tenet

$33.94

0.21 (0.62%)

CYH

Community Health

$3.21

0.005 (0.16%)

HCA

HCA Healthcare

$139.89

-0.72 (-0.51%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

USO

United States Oil Fund

$12.23

0.035 (0.29%)

10:30
12/05/19
12/05
10:30
12/05/19
10:30
General news
EIA natural gas storage change for week ending November 29 »

Gas inventories 19 Bcf…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LB

L Brands

$18.40

-0.29 (-1.55%)

10:25
12/05/19
12/05
10:25
12/05/19
10:25
Options
L Brands call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 27

    Feb

10:25
12/05/19
12/05
10:25
12/05/19
10:25
General news
Treasury Action: yields remains modestly cheaper »

Treasury Action: yields…

ALT

Altimmune

$2.22

0.07 (3.26%)

10:25
12/05/19
12/05
10:25
12/05/19
10:25
Conference/Events
Altimmune to hold a KOL conference call »

Management holds a Key…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

BIIB

Biogen

$287.05

-2.3 (-0.79%)

10:25
12/05/19
12/05
10:25
12/05/19
10:25
Conference/Events
Biogen to host conference call »

Management discusses the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Dec

  • 05

    Dec

  • 05

    Dec

10:25
12/05/19
12/05
10:25
12/05/19
10:25
Conference/Events
House Energy & Commerce Committee to hold a hearing »

The Subcommittee on…

FB

Facebook

$199.20

0.5 (0.25%)

10:23
12/05/19
12/05
10:23
12/05/19
10:23
On The Fly
Street Fight: Analysts diverge on Facebook over regulatory issues, core business »

Shares of Facebook (FB)…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

FB

Facebook

$199.20

0.5 (0.25%)

, NKE

Nike

$95.12

1.4 (1.49%)

10:22
12/05/19
12/05
10:22
12/05/19
10:22
On The Fly
Mixed Facebook views, 'conviction' in Nike among today's top Wall Street calls »

Check out today's top…

FB

Facebook

$199.20

0.5 (0.25%)

NKE

Nike

$95.12

1.4 (1.49%)

GOOGL

Alphabet Class A

$1,318.54

-0.45 (-0.03%)

GOOG

Alphabet

$1,320.00

-1.46 (-0.11%)

AAPL

Apple

$263.80

2.02 (0.77%)

ETSY

Etsy

$39.93

-2.25 (-5.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 09

    Dec

  • 10

    Dec

  • 19

    Dec

10:20
12/05/19
12/05
10:20
12/05/19
10:20
General news
FX Action: The dollar »

FX Action: The dollar was…

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

10:17
12/05/19
12/05
10:17
12/05/19
10:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

10:16
12/05/19
12/05
10:16
12/05/19
10:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:15
12/05/19
12/05
10:15
12/05/19
10:15
General news
U.S. factory orders increased 0.3% in October »

U.S. factory orders…

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.